WallStreetZenWallStreetZen

NASDAQ: GYRE
Gyre Therapeutics Inc Earnings & Revenue

GYRE past revenue growth

How has GYRE's revenue growth performed historically?
Company
10.91%
Industry
165.61%
Market
17.84%
GYRE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GYRE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GYRE's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GYRE earnings and revenue history

Current Revenue
$113.5M
Current Earnings
-$92.9M
Current Profit Margin
-81.9%

GYRE Return on Equity

Current Company
N/A
Current Industry
-63.6%
Current Market
188%

Be the first to know when GYRE announces earnings.

GYRE Return on Assets

Current Company
-235.8%
Current Industry
3%
GYRE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GYRE Return on Capital Employed

Current Company
-87.49%
Current Industry
19.6%
GYRE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GYRE vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GYRE$113.45M-$82.99M-$92.93M+164.06%N/A
ADMA$258.22M$5.12M-$28.24M+72.34%N/A
IMNM$14.02M-$106.08M-$106.81MN/AN/A
IRON$0.00-$75.94M-$76.43MN/AN/A
DAWN$0.00-$188.53M-$188.92MN/AN/A

GYRE earnings dates

Next earnings date
May 13, 2024

Gyre Therapeutics Earnings & Revenue FAQ

What were GYRE's earnings last quarter?

On Invalid Date, Gyre Therapeutics (NASDAQ: GYRE) reported Q4 2023 earnings per share (EPS) of $0.09, up 100.59% year over year. Total Gyre Therapeutics earnings for the quarter were -$89.15 million. In the same quarter last year, Gyre Therapeutics's earnings per share (EPS) was -$15.26.

If you're new to stock investing, here's how to buy Gyre Therapeutics stock.

What was GYRE's earnings growth in the past year?

As of Q1 2024, Gyre Therapeutics's earnings has grown year over year. Gyre Therapeutics's earnings in the past year totalled -$92.93 million.

What is GYRE's earnings date?

Gyre Therapeutics's earnings date is Invalid Date. Add GYRE to your watchlist to be reminded of GYRE's next earnings announcement.

What was GYRE's revenue last quarter?

On Invalid Date, Gyre Therapeutics (NASDAQ: GYRE) reported Q4 2023 revenue of $113.45 million up 11.78% year over year. In the same quarter last year, Gyre Therapeutics's revenue was $101.50 million.

What was GYRE's revenue growth in the past year?

As of Q1 2024, Gyre Therapeutics's revenue has grown 10.91% year over year. This is 154.7 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Gyre Therapeutics's revenue in the past year totalled $113.45 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.